(Q36491569)

14 August 2017

Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome (English)

1 reference

14 August 2017

0 references

S D Mansfield

1

1 reference

14 August 2017

O Barakat

2

1 reference

14 August 2017

R M Charnley

3

1 reference

14 August 2017

B C Jaques

4

1 reference

14 August 2017

C B O'Suilleabhain

5

1 reference

14 August 2017

P J Atherton

6

1 reference

14 August 2017

D Manas

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

48

1 reference

14 August 2017

7625-7630

1 reference

Result of endoscopic biliary drainage in hilar cholangiocarcinoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

One hundred and eleven liver resections for hilar bile duct cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Hilar cholangiocarcinoma: a review and commentary

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Indications for liver transplantation in hepatobiliary malignancy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

What constitutes long-term survival after surgery for hilar cholangiocarcinoma?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Surgery for hilar cholangiocarcinoma: an Italian experience

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Preoperative endoscopic drainage for malignant obstructive jaundice.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4723393

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

21 September 2018

1 reference

12 December 2020

Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents

1 reference

12 December 2020

Pathological aspects of cholangiocarcinoma

1 reference

12 December 2020

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases

1 reference

12 December 2020

Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors.

1 reference

12 December 2020

Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study

1 reference

12 December 2020

Cholangitis after endoscopic biliary drainage for hilar lesions

1 reference

12 December 2020

Rifampicin as cytotoxic agent for cholangiocarcinoma: preliminary report of seven cases

1 reference

12 December 2020

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma

1 reference

12 December 2020

Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy

1 reference

12 December 2020

Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study

1 reference

12 December 2020

Surgical treatment for hilar cholangiocarcinoma

1 reference

12 December 2020

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I48.7625

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16437689

1 reference